Jan 28 (Reuters) - Amgen Inc AMGN.O :
* Health Canada approves amgen's new multiple myeloma treatment Kyprolis(TM)
(carfilzomib)
* Canada says due to the unmet need in this patient population, kyprolis was
granted a priority review by health Canada
* Source text for Eikon ID:nCNWqjzZWa
* Further company coverage AMGN.O